Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/22500
Title: Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function
Authors: K. Pattanapanyasat
H. K. Webster
P. Tongtawe
P. Kongcharoen
R. C. Hider
Mahidol University
Armed Forces Research Institute of Medical Sciences, Thailand
King's College London
Keywords: Medicine
Issue Date: 1-Jan-1992
Citation: British Journal of Haematology. Vol.82, No.1 (1992), 13-19
Abstract: Summary Several iron chelators, 3‐hydroxypyridin‐4‐ones (CP) and desferrioxamine (DF) were compared for their effect on DNA synthesis, cell viability and expression of cell proliferation markers. Short‐term (4 h) exposure of human peripheral blood mononuclear cells to CP or DF inhibited the proliferative response of cells to concanavalin A (Con A). Inhibition by CP and DF showed a dose‐dependent effect with CP compounds more active than DF. Increased inhibitory activity of CP over DF was partly due to the lipophilic properties of CP. Pre‐saturation of CP and DF with exogenous ferric ion either diminished or prevented the inhibitory effect. At high chelator concentrations or prolonged (72 h) exposure of the cells to chelators, inhibition occurred but poor cell viability was observed. In contrast to their inhibition of DNA synthesis, these iron chelators showed little effect on protein synthesis and the expression of transferrin receptors and interleukin‐2 (IL‐2) receptors. These findings suggest that both DF and CP compounds exert their effect by chelation of ferric ion with subsequent inhibition of DNA synthesis. Copyright © 1992, Wiley Blackwell. All rights reserved
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0026744002&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/22500
ISSN: 13652141
00071048
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.